OrthoPediatrics (OrthoPediatrics) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of OrthoPediatrics is: High Risk: High uncertainty.

Competitive Comparison of OrthoPediatrics's Risk Assessment

For the Medical Devices subindustry, OrthoPediatrics's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrthoPediatrics's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Risk Assessment distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Risk Assessment falls into.

OrthoPediatrics (NAS:KIDS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

OrthoPediatrics Risk Assessment Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

OrthoPediatrics (OrthoPediatrics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

2X7:Germany

Address

2850 Frontier Drive, Warsaw, IN, USA, 46582

Website

https://www.orthopediatrics.com

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Executives

Terry D Schlotterback	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Fred Hite	director, officer: Chief Financial Officer	ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Dyer George Sinclair Mitchell	director	55 ORCHARD ST., CAMBRIDGE MA 02140
Gregory A Odle	officer: Executive Vice President	2850 FRONTIER DRIVE, WARSAW IN 46582
Joseph W Hauser	officer: Sr VP & GM Trauma & Deformity	6428 RIDGELINE DR, HUDSON OH 44236
Jimmy Duane Mcdonald	director	28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc	10 percent owner	18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc	10 percent owner	2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf	director	2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C	director	2850 FRONTIER DR, WARSAW IN 46582
Stephen F Burns	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Berry Bernie B Iii	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl	director, officer: President and CEO	ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582